Search

Your search keyword '"Zeniya, M"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Zeniya, M" Remove constraint Author: "Zeniya, M"
225 results on '"Zeniya, M"'

Search Results

1. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

2. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

3. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

4. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

5. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

6. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

7. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

8. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

9. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

10. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

16. International Autoimmune Hepatitis Group* Report: review of criteria for diagnosis of autoimmune hepatitis

17. Health-Related Quality of Life in patients with autoimmune hepatitis

23. PP060-MON: The Nutritional Relationship Between Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

24. Validation of the Japanese version of the Fisk Fatigue Severity Score (FFSS) in Japanese patients with primary biliary cirrhosis

26. PP152-MON NUTRITIONAL ASSESSMENT OF PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS, OBSTRUCTIVE SLEEP APNEA, AND TYPE 2 DIABETES USING FOOD FREQUENCY QUESTIONNAIRES

29. 1305 POSITIVE ANTI-GP210 ANTIBODIES IS A RISK FACTOR FOR POOR BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT IN JAPANESE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS

31. 1109 POSITIVE ANTI-GP210 ANTIBODIES IS A STRONG RISK FACTOR FOR BILE DUCT LOSS AND HEPATITIS WHICH INDUCE JAUNDICE-TYPE PROGRESSION OF PRIMARY BILIARY CIRRHOSIS IN JAPANESE PATIENTS

35. Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study.

39. Autoantibodies to hepatocyte plasma membrane antigens in autoimmune hepatitis: old and new subjects; what do we need?

40. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

41. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

46. Validation of the Japanese version of the Fisk Fatigue Severity Score (FFSS) in Japanese patients with primary biliary cirrhosis

47. Treatment challenges and investigational opportunities in autoimmune hepatitis

48. Autoimmune Hepatitis with Metabolic Dysfunction-associated Fatty Liver Disease.

49. A genome-wide association study identified PTPN2 as a population-specific susceptibility gene locus for primary biliary cholangitis.

50. Changes in lifestyle-related behaviour during the COVID-19 pandemic in Japan: a questionnaire survey for examinees who underwent an annual health check-up.

Catalog

Books, media, physical & digital resources